two new injectable diabetes drugs, Byetta (exenatide) and Symlin (pramlintide)

There's a lot of interest in two new injectable diabetes drugs, Byetta (exenatide) and Symlin (pramlintide).

These drugs are the first of their kind. They both mimic hormones that help regulate blood glucose.

Byetta is an incretin mimetic. It's the one that's based on a protein derived from Gila monster saliva.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote